| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |